Table 1 Comparison of lipid profiles {TC, TG, and HDL-C levels} (mg/dl) of various experimental groups at baseline and at the end of 90 days
Group (n = 6) | TC—baseline | TC—90 days | TG—baseline | TG—90 days | HDL-C baseline | HDL-C 90 days |
|---|---|---|---|---|---|---|
Group I: normal control (N) | 124.07 ± 1.39 | 125.99 ± 1.56 | 86.81 ± 2.87 | 89.48 ± 2.26 | 64.55 ± 2.99 | 65.98 ± 2.84 |
Group II: OLZ (O) | 124.16 ± 1.98 | 163.16 ± 4.07μδ | 86.17 ± 2.93 | 127.57 ± 2.85μδ | 62.26 ± 1.92 | 49.86 ± 2.14κλ#£ |
Group III: probiotic I (probiotic low dose)—PM | 126.46 ± 1.79 | 108.90 ± 1.87γ | 87.74 ± 2.68 | 87.41 ± 1.16Å | 58.97 ± 2.55 | 75.53 ± 2.02γ |
Group IV: probiotic II (probiotic high dose)—PH | 123.76 ± 1.82 | 112.27 ± 1.34γ | 85.17 ± 2.78 | 82.07 ± 1.59Å | 60.99 ± 2.97 | 70.50 ± 2.82γ |
Group V: OLZ + probiotic-I (TM) | 120.43 ± 1.84 | 118.32 ± 2.08μκ@ | 86.56 ± 1.73 | 90.10 ± 2.37Å | 58.95 ± 2.90 | 62.50 ± 2.88*κλ |
Group VI: OLZ + probiotic-II (TH) | 120.67 ± 1.19 | 123.08 ± 1.52μκλ | 85.60 ± 2.48 | 89.30 ± 1.70Å | 60.86 ± 2.38 | 58.55 ± 1.41κλ |